Outsourcing Renewal Applications Frees Up Internal Resources
Medaffcon prepares around 25–30 renewal applications each year for approximately 10–15 clients. The volume ensures well-established routines and consistently high quality.
Risk-sharing agreements (RSA) are one of the most interesting and debated topics in the Finnish Market Access scene at the moment. Medaffcon has been studying the agreements, their application and experiences in using them and has also been participating in building several risk-sharing agreements in Finland, both in ambulatory care (with Pharmaceutical Pricing Board) and hospital care (with hospitals).
Learn more about RSA’s from the interview with Pekka Männistö from the video below.
Market Access, pricing and reimbursement of medicines in Finland – This article provides information of the market access options and current pricing system in Finland, in ambulatory and hospital care.
Medaffcon prepares around 25–30 renewal applications each year for approximately 10–15 clients. The volume ensures well-established routines and consistently high quality.
Pharmaceutical companies’ product portfolios are valuable assets, yet they may remain underutilised. How to unlock the full potential of a drug portfolio?
The United States is seeking to curb pharmaceutical expenditure by incorporating international price referencing into public health insurance programs.